Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
Titel:
Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
Auteur:
Yap, Timothy A Nakagawa, Kazuhiko Fujimoto, Nobukazu Kuribayashi, Kozo Guren, Tormod Kyrre CalabrĂ², Luana Shapira-Frommer, Ronnie Gao, Bo Kao, Steven Matos, Ignacio Planchard, David Chatterjee, Arkendu Jin, Fan Norwood, Kevin Kindler, Hedy L